 |
인쇄하기
취소
|
GSK keeps top spot in 2012 sales
GSK kept its number 1 ranking in terms of revenue last year from the leader board of multinational drug makers, but struggles this year against Novartis Korea which continued to overtake the top position, according to Yakup.com, a pharmaceutical information provider.
According to the data recompiled by Yakup.com, GSK saw its revenue fall 6.5 percent to 473.2 billion won from a year earlier. ...
According to the data recompiled by Yakup.com, GSK saw its revenue fall 6.5 percent to 473.2 billion won from a year earlier. ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.